BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33420290)

  • 1. Usefulness of selective arterial calcium injection tests for functional pancreatic neuroendocrine tumors.
    Nakano Y; Kitago M; Shinoda M; Nakatsuka S; Kurihara I; Yagi H; Abe Y; Oshima G; Hori S; Yokose T; Kitagawa Y
    Sci Rep; 2021 Jan; 11(1):235. PubMed ID: 33420290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
    Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
    J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of pancreatic neuroendocrine tumors: an introduction.
    Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery for pancreatic neuroendocrine tumors].
    Shibata C; Egawa S; Motoi F; Morikawa T; Naitoh T; Unno M; Sasaki I
    Nihon Geka Gakkai Zasshi; 2012 Nov; 113(6):502-6. PubMed ID: 23330458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
    Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
    Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Size on Microscopy, CT, and MRI Assessments Versus Pathologic Gross Specimen Analysis of Pancreatic Neuroendocrine Tumors.
    Bian Y; Li J; Jiang H; Fang X; Cao K; Ma C; Lu J
    AJR Am J Roentgenol; 2021 Jul; 217(1):107-116. PubMed ID: 33978449
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours.
    Alsohaibani F; Bigam D; Kneteman N; Shapiro AM; Sandha GS
    Can J Gastroenterol; 2008 Oct; 22(10):817-20. PubMed ID: 18925304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential value of EUS in pancreatic surveillance of VHL patients.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
    Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
    Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
    Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.
    Rozenblum L; Mokrane FZ; Yeh R; Sinigaglia M; Besson F; Seban RD; Chougnet CN; Revel-Mouroz P; Zhao B; Otal P; Schwartz LH; Dercle L
    Abdom Radiol (NY); 2019 Jul; 44(7):2474-2493. PubMed ID: 30980115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.